4016 Organometallics, Vol. 25, No. 16, 2006
Ojo et al.
eter at the Laboratoire de Biochimie, Faculte´ de Me´decine (Brest,
France). The NMR spectra (1H, 13C) were recorded at room
temperature in CDCl3, C6D6, or (CD3)2CO solutions with a Bruker
AMX 400 spectrometer and were referenced to SiMe4. 1H-13C and
1H-15N 2D experiments were carried out on a Bruker DRX 500
spectrometer.
Synthesis of [Mo2Cp2(µ-SMe)3(MeCN)(xylNC)](BF4) (3). A
solution of complex 1 (200 mg, 0.317 mmol) in dichloromethane
(30 mL) was stirred in the presence of 1 equiv of xylNC (41.5 mg)
for 4 h at room temperature. The color of the solution turned from
red to orange. The volume of the solution was reduced under
vacuum, and diethyl ether (50 mL) was added to precipitate a
maroon powder that was washed twice with pentane (2 × 15 mL).
After drying, compound 3 was obtained; its NMR spectra were
those expected of a pure sample (163 mg, 71% yield) and gave its
structure without ambiguity. IR (KBr, cm-1): ν(CN) 2075 (s), ν(BF)
1150-1050 (s). 1H NMR [(CD3)2CO]: δ 7.28-6.82 (m, 3H, C6H3-
(CH3)2), 5.64 (s, 5H, C5H5), 5.41 (s, 5H, C5H5), 2.45 (s, 6H, C6H3-
(CH3)2), 2.20 (s, 3H, CH3CN), 1.81 (s, 3H, SCH3), 1.80 (s, 3H,
SCH3), 1.56 (s, 3H, SCH3).
Reaction of [Mo2Cp2(µ-SMe)3(xylNC)2](BF4) (2b) with NaOH:
Synthesis of [Mo2Cp(µ-SMe)3{µ-(η5-C5H4)(xylN)CN(xyl)C}] (4).
The complex 2b (400 mg, 0.492 mmol) and a large excess of NaOH
(201 mg, 5 mmol) were heated in tetrahydrofuran (30 mL) at reflux
for 24 h. After filtration, the solvent was removed under vacuum
and one organometallic product was extracted with diethyl ether
(3 × 10 mL). Evaporation of volatiles afforded complex 4 as a red
powder, which was washed twice with pentane (2 × 15 mL) (300
mg, 84% yield). Anal. Calcd for C31H36Mo2N2S3: C, 51.4; H, 5.0;
N, 3.9. Found: C, 51.7; H, 5.0; N, 3.9. IR (KBr, cm-1): ν(CN)
1642 (m). 1H NMR [(CD3)2CO]: δ 7.17-6.96 (m, 6H, C6H3(CH3)2),
6.00 (m, 1H, C5H4), 5.66 (m, 1H, C5H4), 5.29 (m, 1H, C5H4), 5.10
(s, 5H, C5H5), 5.00 (m, 1H, C5H4), 2.29 (s, 3H, CH3(xyl)), 2.27 (s,
3H, CH3(xyl)), 2.17 (s, 6H, CH3(xyl)), 1.89 (s, 3H, SCH3), 1.82
(s, 3H, SCH3), 1.60 (s, 3H, SCH3). 13C{1H}NMR (C6D6): δ 374.7
(Mo2C), 156.5 (CdN), 147.3, 143.1, 137.2, 134.2, 128.8, 128.6,
123.4 (C6H3(CH3)2), 105.9, 103.6, 95.9 (C5H4), 92.0 (C5H5), 90.6,
84.3 (C5H4), 29.2 (SCH3), 20.3, 19.4 (C6H3(CH3)2), 8.0 (SCH3),
6.6 (SCH3).
and 5b2, in a 11:1 ratio by chromatography. When the reaction
was conducted under reflux for 72 h, compound 5b was recovered
in lower yields (71 mg, 74.5%), but isomers 5b1 and 5b2 were
then obtained in a 1:10 ratio (1H NMR analysis).
Method C. Complex 5b2 can also be synthesized in moderate
yields (48%) by refluxing a tetrahydrofuran solution of the above
mixture of 5b1 (92%) and 5b2 (8%) for 72 h (1H NMR analysis
only). However, this thermal reaction gave rise to appreciable
decomposition of 5b into an unidentified product (∼31%).
Orange crystals of 5a1, 5b1, and 5b2, suitable for X-ray analysis,
were obtained by crystallization at room temperature from a
CH2Cl2 solution layered with diethyl ether. Analytical data for 5a1
have been confirmed by electrospray mass spectroscopy. The
observed characteristic multiplets, caused by the polyisotopic nature
of Mo, N, and S, allowed an unambiguous assignment of the
detected signals: in particular, the upper parts of the spectrum of
5a1 were dominated by the molecular ion [M]+ . Full 13C NMR
assignments of compounds 5a1 and 5b were based on 1H-13C and
1H-15N HMBC experiments.
5a1. Anal. Calcd for C39H43 Mo2N3OS2: C, 56.7; H, 5.25; N,
5.0. Found: C, 55.7; H, 5.4; N, 4.5. ESI-MS (m/z): 825.6 [M]+. IR
(KBr, cm-1): ν(NH) 3412 (s), ν(CN) 1637 (s). 1H NMR (CDCl3):
δ 7.36 (s, 1H, NH), 7.17-6.72 (m, 9H, C6H3Me2), 5.22 (pt, JH-H
) 2.0 Hz, 2H, C5H4), 4.98 (s, 5H, C5H5), 4.49 (pt, JH-H ) 2.0 Hz,
2H, C5H4), 2.26, 2.21, 2.07 (s, 6H, CH3(xyl)), 1.81 (s, 6H, SCH3).
13C{1H} NMR (CDCl3): δ 369.3 (Mo2C), 248.4 (MoCO), 155.5
(CdN), 146.4, 141.8, 138.0, 135.5, 128.4, 128.3, 127.7, 127.4,
122.4, 122.2 (C6H3Me2), 98.6 (C5H4), 92.8 (Ci(C5H4)), 92.7 (C5H5),
87.4 (C5H4), 20.5, 19.1, 18.3 (CH3(xyl)), 15.3 (SCH3).
5b. Anal. Calcd for C35H43Mo2N3OS2: C, 54.05; H, 5.6; N, 5.4.
Found: C, 54.5; H, 5.3; N, 4.8. IR (KBr, cm-1), 5b1: ν(NH) 3424
1
(s), ν(CN) 1643 (m); 5b2: ν(NH) 3456 (vs), ν(CN) 1654 (s). H
NMR (CDCl3), 5b1: δ 7.11, 6.91, and 6.80 (m, 6H, C6H3Me2),
5.65 (s, br, 1H, NH), 5.45 (s, 4H, C5H4), 4.93 (s, 5H, C5H5), 2.20,
2.15 (s, 6H, C6H3Me2), 1.81 (s, 6H, SCH3), 1.33 (s, 9H, CMe3);
5b2: δ 7.11, 6.85, and 6.77 (m, 6H, C6H3Me2), 5.72 (pt, JH-H
)
2.2 Hz, C5H4), 5.65 (s, br, NH), 5.48 (pt, JH-H ) 2.2 Hz, 2H, C5H4),
4.77 (s, 5H, C5H5), 2.14 (s, 12H, C6H3Me2), 1.80 (s, 6H, SCH3),
1
1.34 (s, 9H, CMe3). H NMR (C6D6), 5b1: δ 6.97, 6.87, and 6.79
Reaction of [Mo2Cp2(µ-SMe)3(xylNC)2](BF4) (2b) with Hy-
droxide in the Presence of Excess RNC: Preparation of [Mo2Cp-
(µ-SMe)2 {µ-(η5-C5H4)(xylN)CN(xyl)C}{µ-OCNHR}] [R ) xyl
(5a1), But (5b1, 5b2)]. Method A. Complex 2b (500 mg, 0.615
mmol) was treated with an excess of NaOH (201 mg) in the
presence of 3 equiv of xylNC (242 mg) in refluxing tetrahydrofuran
(50 mL) for 72 h. Then NaOH in excess and Na(BF4) were
eliminated by filtration, and the solvent was removed under reduced
pressure. The resulting residue was washed three time with cold
diethyl ether (3 × 15 mL), affording complex 5a1 as an orange
powder (449 mg, 88% yield).
Complex 5b (5b2) was obtained by a procedure like that
described for the synthesis of 5a1, by reacting 2b (600 mg, 0.738
mmol) with an excess of NaOH (201 mg) in the presence of 3
equiv of ButNC (V ) 253 µL) in tetrahydrofuran (50 mL) and
extracting compound 5b2 from the residue with diethyl ether (3 ×
15 mL) at room temperature. Evaporation of the solvent afforded
5b2 as an orange powder (401 mg, 70% yield).
Method B. Complex 5b can also be prepared as a mixture of
two isomers, 5b1 and 5b2, by a process like that described above,
but using Me4NOH in MeOH (2.2 M) instead of NaOH.
In a typical procedure, a mixture of 2b (100 mg, 0.123 mmol)
and an excess of Me4NOH (V ) 168 µL) in the presence of 3 equiv
of ButNC (V ) 42 µL) in tetrahydrofuran (20 mL) was refluxed
for 2 h. Insoluble materials were eliminated by filtration, the solvent
was removed under pressure, and the residue was washed with cold
(-60 °C) diethyl ether (3 × 15 mL) to give orange powders of 5b
(78.5 mg, 82% yield) as a mixture of two inseparable isomers, 5b1
(m, 6H, C6H3Me2), 5.57 (pt, JH-H ) 2.2 Hz, 2H, C5H4), 5.55 (s,
1H, NH), 5.15 (pt, JH-H ) 2.2 Hz, 2H, C5H4), 5.00 (s, 5H, C5H5),
2.39, 2.20 (s, 6H, C6H3Me2), 1.98 (s, 6H, SCH3), 1.24 (s, 9H, CMe3);
5b2: δ 6.99, 6.95, and 6.84 (m, 6H, C6H3Me2), 5.50 (pt, JH-H
2.2 Hz, 2H, C5H4), 5.50 (s concealed, 1H, NH), 5.38 (pt, JH-H
)
)
2.2 Hz, 2H, C5H4), 4.82 (s, 5H, C5H5), 2.34, 2.18 (s, 6H, C6H3Me2),
1.98 (s, 6H, SCH3), 1.25 (s, 9H, CMe3). 13C{1H} NMR (CDCl3),
5b1: δ 362.7 (Mo2C), 242.9 (MoCO), 155.3 (CdN), 146.9, 142.1
(Ci (xyl)), 135.4, 128.2, 128.1, 127.8, 127.75, 127.6, 122.6
(C6H3Me2), 112.5 (Ci (C5H4)), 100.2 (C5H4), 92.5 (C5H5), 85.0
(C5H4), 53.5 (CMe3), 30.6 (CMe3), 19.2, 18.25 (CH3(xyl)), 15.3
(SCH3); 5b2: 366.4 (Mo2C), 242.7 (MoCO), 156.0 (CdN), 147.2,
142.9 (Ci (xyl)), 135.7 (C6H3Me2), 128.0-127.5 (C6H3Me2), 106.6
(Ci (C5H4)), 100.1 (C5H4), 91.6 (C5H5), 88.4 (C5H4), 53.7 (CMe3),
30.3 (CMe3), 19.0, 18.5 (CH3(xyl)), 15.4 (SCH3).
Reaction of [Mo2Cp(µ-SMe)3{µ-(η5-C5H4)(xylN)CN(xyl)C}]
(4) with Sodium Hydroxide in the Presence of RNC (R ) xyl,
But): Formation of 5a1 and 5b2. Complex 4 (100 mg, 0.138
mmol) was treated with an excess of NaOH (201 mg) in the
presence of 2 equiv of RNC [R ) xyl (32.5 mg), But (V ) 31 µL)]
in refluxing tetrahydrofuran (30 mL) for 24 h. After filtration the
solvent was removed under reduced pressure and the residue washed
three time with cold diethyl ether (3 × 15 mL), affording orange
powders of 5a1 (60.5 mg, 53% yield) or 5b2 (50 mg, 55% yield).
Reaction of 2b with Tetramethylammonium Hydroxide in
the Presence of xylNC: Preparation of [Mo2Cp(µ-SMe)2{µ-(η5-
C5H4)(xylN)CN(xyl)C}{µ-OCNMe xyl}] (6a). To a tetrahydro-
furan solution (50 mL) of [Mo2Cp2(µ-SMe)3(xylNC)2](BF4) (2b)